Olr792 inhibitors represent a novel class of chemical compounds that target the Olfactory Receptor 792 (Olr792). These inhibitors function by binding to the receptor, which is a part of the G protein-coupled receptor (GPCR) family, known for their significant role in various cellular signaling pathways. Olr792, specifically, is involved in the olfactory system, where it contributes to the detection of odorant molecules. The inhibitors designed for Olr792 are characterized by their ability to precisely interact with the receptor's active site, thereby modulating its activity. The chemical structures of Olr792 inhibitors often include aromatic rings, heterocyclic compounds, and various functional groups that enable them to fit snugly within the receptor's binding pocket. This precise fit is crucial for the inhibitor's efficacy, as it ensures that the receptor's normal function is altered in a controlled manner. The development of these inhibitors involves extensive computational modeling and synthetic chemistry to optimize their interaction with Olr792.
The synthesis of Olr792 inhibitors typically follows a multi-step organic synthesis pathway, where each step is meticulously planned to build the complex molecular framework required for high-affinity binding. Advanced techniques such as click chemistry, palladium-catalyzed cross-coupling reactions, and selective functional group modifications are often employed. Characterization of these inhibitors is carried out using various spectroscopic methods, including NMR, IR, and mass spectrometry, to confirm their structure and purity. Additionally, in vitro assays are performed to assess their binding affinity and specificity towards Olr792. These assays involve the use of recombinant cells expressing the Olr792 receptor, where the inhibitors' effects on receptor activity can be quantitatively measured. The study of Olr792 inhibitors extends into understanding their interaction dynamics and the conformational changes induced in the receptor upon binding, utilizing techniques such as X-ray crystallography and cryo-electron microscopy. These detailed studies provide insights into the fundamental principles governing receptor-ligand interactions, paving the way for the design of even more effective inhibitors.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Propranolol | 525-66-6 | sc-507425 | 100 mg | $180.00 | ||
Beta-adrenergic antagonist, might modulate GPCR activity affecting Olr792. | ||||||
Carvedilol | 72956-09-3 | sc-200157 sc-200157A sc-200157B sc-200157C sc-200157D | 100 mg 1 g 10 g 25 g 100 g | $124.00 $240.00 $530.00 $999.00 $1530.00 | 2 | |
Beta-adrenergic antagonist with alpha-1 blocking activity, could influence Olr792 signaling. | ||||||
Yohimbine hydrochloride | 65-19-0 | sc-204412 sc-204412A sc-204412B | 1 g 5 g 25 g | $51.00 $171.00 $530.00 | 2 | |
Alpha-2 adrenergic receptor antagonist, may affect GPCR signaling pathways related to Olr792. | ||||||
Labetalol | 36894-69-6 | sc-484723 | 50 mg | $180.00 | ||
Combined alpha and beta blocker, could indirectly affect GPCR pathways including Olr792. | ||||||
Pindolol | 13523-86-9 | sc-204847 sc-204847A | 100 mg 1 g | $194.00 $760.00 | ||
Beta-adrenergic antagonist, may influence GPCR-mediated signaling pathways related to Olr792. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Beta-adrenergic agonist, could indirectly affect Olr792 through GPCR modulation. | ||||||
Atropine | 51-55-8 | sc-252392 | 5 g | $204.00 | 2 | |
Muscarinic acetylcholine receptor antagonist, may influence GPCR signaling pathways including Olr792. | ||||||
Salmeterol | 89365-50-4 | sc-224277 sc-224277A | 10 mg 50 mg | $186.00 $562.00 | 1 | |
Beta-2 adrenergic agonist, potentially affecting GPCR pathways related to Olr792. | ||||||
Alprenolol | 13655-52-2 | sc-507469 | 50 mg | $130.00 | ||
Beta blocker, could indirectly influence GPCR signaling pathways including Olr792. | ||||||